1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Demographics of the study population
Cohort Featuresn = 88 (%, or range)
Female (%)52 (59)
Avg. age (range) (yr)48.5 (22–78)
White (%)70 (80)
Polyps (%)59 (67)
Asthma (%)53 (60)
AERD (%)8 (9)
Never smoker (%)55 (62)
Prior surgery (%)48 (55)
Avg. absolute serum eosinophils × 109/L0.31 (0–2.6)
Avg. tissue eosinophils per HPF80 (0–413)
Avg. SNOT-2249.6 (15–95)
Avg. LKS6.8 (1–12)
Avg. LMS13.5 (2–24)
Avg. GOSS2.7 (0–35)
Avg. sinus cavity volume (mL)60.8 (24.8–109.0)
Avg. %SO60.1 (20.7–99.6)
Avg. mHU10.5 (−139.2 to +57.4)
Avg. %OST41.4 (32.1–52.2)
  • Note:—AERD indicates aspirin-exacerbated respiratory disease; HPF, high-power field; Avg., average.